Matteo Bruschettini , Daniël L.A. van den Hove , Diego Gazzolo , Pierluigi Bruschettini , Carlos E. Blanco , Harry W.M. Steinbusch
{"title":"产前单疗程倍他米松可降低新生大鼠海马和血清中神经营养因子S100B的浓度","authors":"Matteo Bruschettini , Daniël L.A. van den Hove , Diego Gazzolo , Pierluigi Bruschettini , Carlos E. Blanco , Harry W.M. Steinbusch","doi":"10.1016/j.devbrainres.2005.07.003","DOIUrl":null,"url":null,"abstract":"<div><p><span>The effects of a single course of antenatal betamethasone<span> on S100B protein concentration were investigated in Fisher 344 rats. On day 20 of gestation, pregnant rats were injected twice 8 h apart with either (1) 170 μg kg</span></span><sup>−1</sup><span><span><span> body weight betamethasone (“clinically-equivalent dose”, equivalent to 12 mg twice, 24 h apart in humans), (2) half of this dose (equivalent to 6 mg) or (3) vehicle. We report reference values for S100B protein in the serum and different brain regions in both genders at 1, 2, and 21 days after birth. Interestingly, S100B concentration showed a time-dependent and brain region-specific pattern of expression. At P1, S100B was higher in the serum of males compared to females. In addition, we show that both doses of betamethasone decreased S100B concentration in the serum of males at P1, whereas in the </span>hippocampus, it was reduced by the clinically-equivalent dose only. This suggests that lowering the dose of antenatal betamethasone may be less detrimental for brain maturation and therefore we reiterate the need for clinical trials with a low </span>dose regimen.</span></p></div>","PeriodicalId":100369,"journal":{"name":"Developmental Brain Research","volume":"159 2","pages":"Pages 113-118"},"PeriodicalIF":0.0000,"publicationDate":"2005-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.devbrainres.2005.07.003","citationCount":"21","resultStr":"{\"title\":\"A single course of antenatal betamethasone reduces neurotrophic factor S100B concentration in the hippocampus and serum in the neonatal rat\",\"authors\":\"Matteo Bruschettini , Daniël L.A. van den Hove , Diego Gazzolo , Pierluigi Bruschettini , Carlos E. Blanco , Harry W.M. Steinbusch\",\"doi\":\"10.1016/j.devbrainres.2005.07.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p><span>The effects of a single course of antenatal betamethasone<span> on S100B protein concentration were investigated in Fisher 344 rats. On day 20 of gestation, pregnant rats were injected twice 8 h apart with either (1) 170 μg kg</span></span><sup>−1</sup><span><span><span> body weight betamethasone (“clinically-equivalent dose”, equivalent to 12 mg twice, 24 h apart in humans), (2) half of this dose (equivalent to 6 mg) or (3) vehicle. We report reference values for S100B protein in the serum and different brain regions in both genders at 1, 2, and 21 days after birth. Interestingly, S100B concentration showed a time-dependent and brain region-specific pattern of expression. At P1, S100B was higher in the serum of males compared to females. In addition, we show that both doses of betamethasone decreased S100B concentration in the serum of males at P1, whereas in the </span>hippocampus, it was reduced by the clinically-equivalent dose only. This suggests that lowering the dose of antenatal betamethasone may be less detrimental for brain maturation and therefore we reiterate the need for clinical trials with a low </span>dose regimen.</span></p></div>\",\"PeriodicalId\":100369,\"journal\":{\"name\":\"Developmental Brain Research\",\"volume\":\"159 2\",\"pages\":\"Pages 113-118\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2005-10-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.devbrainres.2005.07.003\",\"citationCount\":\"21\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Developmental Brain Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0165380605002063\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Developmental Brain Research","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0165380605002063","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 21
摘要
研究了产前单疗程倍他米松对Fisher 344大鼠S100B蛋白浓度的影响。在妊娠第20天,给怀孕大鼠注射两次倍他米松,每次间隔8小时:(1)170 μg kg - 1体重的倍他米松(“临床等效剂量”,相当于人类每隔24小时注射两次12mg倍他米松),(2)该剂量的一半(相当于6mg)或(3)载药。我们报告了出生后1、2和21天男女血清和不同脑区S100B蛋白的参考值。有趣的是,S100B浓度表现出时间依赖性和脑区域特异性的表达模式。P1时,雄性血清中S100B含量高于雌性。此外,我们发现两种剂量的倍他米松在P1时降低了雄性血清中的S100B浓度,而在海马中,它仅被临床等效剂量降低。这表明,降低产前倍他米松剂量可能对大脑成熟的危害较小,因此我们重申需要进行低剂量方案的临床试验。
A single course of antenatal betamethasone reduces neurotrophic factor S100B concentration in the hippocampus and serum in the neonatal rat
The effects of a single course of antenatal betamethasone on S100B protein concentration were investigated in Fisher 344 rats. On day 20 of gestation, pregnant rats were injected twice 8 h apart with either (1) 170 μg kg−1 body weight betamethasone (“clinically-equivalent dose”, equivalent to 12 mg twice, 24 h apart in humans), (2) half of this dose (equivalent to 6 mg) or (3) vehicle. We report reference values for S100B protein in the serum and different brain regions in both genders at 1, 2, and 21 days after birth. Interestingly, S100B concentration showed a time-dependent and brain region-specific pattern of expression. At P1, S100B was higher in the serum of males compared to females. In addition, we show that both doses of betamethasone decreased S100B concentration in the serum of males at P1, whereas in the hippocampus, it was reduced by the clinically-equivalent dose only. This suggests that lowering the dose of antenatal betamethasone may be less detrimental for brain maturation and therefore we reiterate the need for clinical trials with a low dose regimen.